Highly variable expression of virus receptors in the human cardiovascular system. Implications for cardiotropic viral infections and gene therapy.

Prevalence of myocarditis and cardiotropic virus infection in Africans with HIV-associated cardiomyopathy, idiopathic dilated cardiomyopathy and heart transplant recipients: a pilot study: cardiovascular topic. Cardiovasc J Afr (2013) 1.41

Herpesvirus-mediated delivery of a genetically encoded fluorescent Ca(2+) sensor to canine cardiomyocytes. J Biomed Biotechnol (2009) 0.89

Inflammation, ECG changes and pericardial effusion: whom to biopsy in suspected myocarditis? Clin Res Cardiol (2006) 0.85

Spatiotemporal changes of coxsackievirus and adenovirus receptor in rat hearts during postnatal development and in cultured cardiomyocytes of neonatal rat. Virchows Arch (2003) 0.85

High prevalence of cardiac parvovirus B19 infection in patients with isolated left ventricular diastolic dysfunction. Circulation (2005) 1.84

[18-year old patient with anti-epileptic therapy and sudden cardiac death]. Z Kardiol (2003) 1.41

Tissue-specific transcription pattern of the adenine nucleotide translocase isoforms in humans. FEBS Lett (1997) 1.31

Inhibition of p38 mitogen-activated protein kinase attenuates left ventricular dysfunction by mediating pro-inflammatory cardiac cytokine levels in a mouse model of diabetes mellitus. Diabetologia (2006) 1.29

Immunohistological evidence for a chronic intramyocardial inflammatory process in dilated cardiomyopathy. Heart (1996) 1.23

Prevalence of erythrovirus genotypes in the myocardium of patients with dilated cardiomyopathy. J Med Virol (2008) 1.18

microRNA122-regulated transgene expression increases specificity of cardiac gene transfer upon intravenous delivery of AAV9 vectors. Gene Ther (2010) 1.16

Genomic expression profiling of human inflammatory cardiomyopathy (DCMi) suggests novel therapeutic targets. J Mol Med (Berl) (2006) 1.12

Anti-inflammatory effects of atorvastatin improve left ventricular function in experimental diabetic cardiomyopathy. Diabetologia (2007) 1.10

Human coxsackie-adenovirus receptor is colocalized with integrins alpha(v)beta(3) and alpha(v)beta(5) on the cardiomyocyte sarcolemma and upregulated in dilated cardiomyopathy: implications for cardiotropic viral infections. Circulation (2001) 1.09

Relation between circulating angiotensin II type 1 receptor agonistic autoantibodies and soluble fms-like tyrosine kinase 1 in the pathogenesis of preeclampsia. J Clin Endocrinol Metab (2006) 1.04

Differential internalization and nuclear uncoating of self-complementary adeno-associated virus pseudotype vectors as determinants of cardiac cell transduction. Gene Ther (2007) 0.98

Fractalkine in human inflammatory cardiomyopathy. Heart (2011) 0.93

HDL is the major source of vitamin E for type II pneumocytes. Free Radic Biol Med (1999) 0.93

Mesenchymal stem cells improve murine acute coxsackievirus B3-induced myocarditis. Eur Heart J (2010) 0.92

Alternatively spliced tissue factor and full-length tissue factor protect cardiomyocytes against TNF-α-induced apoptosis. J Mol Cell Cardiol (2012) 0.91

Highly efficient and specific modulation of cardiac calcium homeostasis by adenovector-derived short hairpin RNA targeting phospholamban. Gene Ther (2006) 0.90

Coxsackievirus B3 and adenovirus infections of cardiac cells are efficiently inhibited by vector-mediated RNA interference targeting their common receptor. Gene Ther (2007) 0.90

Involvement of p32 and microtubules in alteration of mitochondrial functions by rubella virus. J Virol (2011) 0.88

Adenovirus-based phospholamban antisense expression as a novel approach to improve cardiac contractile dysfunction: comparison of a constitutive viral versus an endothelin-1-responsive cardiac promoter. Circulation (2000) 0.88

Regulation by vitamin E of the scavenger receptor BI in rat liver and HepG2 cells. J Lipid Res (2000) 0.86

Enhancement of endothelial nitric oxide synthase production reverses vascular dysfunction and inflammation in the hindlimbs of a rat model of diabetes. Diabetologia (2008) 0.86

Inflammation, ECG changes and pericardial effusion: whom to biopsy in suspected myocarditis? Clin Res Cardiol (2006) 0.85

Immunohistochemistry in dilated cardiomyopathy. Eur Heart J (1995) 0.85

A novel tetracycline-controlled transactivator-transrepressor system enables external control of oncolytic adenovirus replication. Gene Ther (2003) 0.85

Molecular characterisation of the defective alpha 1-antitrypsin alleles PI Mwurzburg (Pro369Ser), Mheerlen (Pro369Leu), and Q0lisbon (Thr68Ile). Eur J Hum Genet (1999) 0.83

Mesenchymal stem cells and inflammatory cardiomyopathy: cardiac homing and beyond. Cardiol Res Pract (2011) 0.83

Expression of fatty-acid-binding proteins in cells involved in lung-specific lipid metabolism. Eur J Biochem (1998) 0.81

Transgenic overexpression of the adenine nucleotide translocase 1 protects cardiomyocytes against TGFβ1-induced apoptosis by stabilization of the mitochondrial permeability transition pore. J Mol Cell Cardiol (2012) 0.81

Mesenchymal stromal cells: a promising cell source for the treatment of inflammatory cardiomyopathy. Curr Pharm Des (2011) 0.81

Genome-environment interactions in the molecular pathogenesis of dilated cardiomyopathy. J Mol Med (Berl) (2005) 0.80

miRNA as activity markers in Parvo B19 associated heart disease. Herz (2012) 0.80

Vascular involvement in cardiac giant cell myocarditis: a new pathophysiological aspect. Clin Res Cardiol (2013) 0.79

A distinct subgroup of cardiomyopathy patients characterized by transcriptionally active cardiotropic erythrovirus and altered cardiac gene expression. Basic Res Cardiol (2013) 0.79

Chronic inflammation in the myocardium of patients with clinically suspected dilated cardiomyopathy. J Card Fail (1994) 0.79

Development of novel cardiovascular therapeutics from small regulatory RNA molecules--an outline of key requirements. Curr Pharm Des (2010) 0.79

Cell-mediated cytotoxicity in hearts with dilated cardiomyopathy: correlation with interstitial fibrosis and foci of activated T lymphocytes. J Am Coll Cardiol (1997) 0.78

Treatment of coxsackievirus-B3-infected BALB/c mice with the soluble coxsackie adenovirus receptor CAR4/7 aggravates cardiac injury. J Mol Med (Berl) (2006) 0.78

Tamoxifen-regulated adenoviral E1A chimeras for the control of tumor selective oncolytic adenovirus replication in vitro and in vivo. Gene Ther (2006) 0.78

Paradoxical embolization of brachiocephalic and pulmonary arteries in a case of persistent foramen ovale: a case report. Thorac Cardiovasc Surg (2011) 0.78

Effects of mesenchymal stromal cells on diabetic cardiomyopathy. Curr Pharm Des (2011) 0.78

The angiotensin-(1-7) receptor agonist AVE0991 dominates the circadian rhythm and baroreflex in spontaneously hypertensive rats. J Cardiovasc Pharmacol (2007) 0.76

Enteroviral and immune mediated myocarditis in SCID mice. Herz (2000) 0.75

[Cardiomyopathies II. Hypertrophic cardiomyopathy, restrictive cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy]. Internist (Berl) (2005) 0.75

Catheter based intracoronary brachytherapy leads to increased platelet activation. Heart (2004) 0.75

Clopidogrel-mediated reduction of circulating tissue factor in patients with stable coronary artery disease. Eur J Haematol (2007) 0.75

New therapeutics targets in chronic viral cardiomyopathy. Ernst Schering Res Found Workshop (2006) 0.75

[Polymerase chain reaction (PCR) for detection of BLV provirus-- a practical complement for BLV diagnosis?]. Berl Munch Tierarztl Wochenschr (1998) 0.75

[Pericardial effusions, cardiac tamponade, armored heart. Preventing sequelae of pericarditis]. MMW Fortschr Med (2002) 0.75

A nucleotide deletion causing a translational stop in the protease reading frame of bovine leukaemia virus (BLV) results in modified protein expression and loss of infectivity. J Vet Med B Infect Dis Vet Public Health (2000) 0.75

Long-term clopidogrel administration following severe coronary injury reduces proliferation and inflammation via inhibition of nuclear factor-kappaB and activator protein 1 activation in pigs. Eur J Clin Invest (2009) 0.75

[Possibilities and limitations for use of the polymerase chain reaction (PCR) in the diagnosis of bovine leukemia virus (BLV) infection in cattle]. Dtsch Tierarztl Wochenschr (1998) 0.75

Nucleic acid-based modulation of cardiac gene expression for the treatment of cardiac diseases. Approaches and perspectives. Z Kardiol (2004) 0.75

The German Transregional Collaborative Research Centre 'Inflammatory Cardiomyopathy--Molecular Pathogenesis and Therapy'. Methods and baseline results from a 3-centre clinical study. Cardiology (2009) 0.75

[Cardiomyopathies. I: classification of cardiomyopathies--dilated cardiomyopathy]. Internist (Berl) (2005) 0.75